Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if a therapy using docetaxel
chemotherapy with hormonal therapy taken before your scheduled surgery is beneficial to
treatment of prostate cancer. The safety of this combination will also be studied.